Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa
It is explored for its role in supporting cellular recovery, angiogenesis, and protective biological pathways
Retatrutide is a novel investigational peptide that acts as an agonist for three receptors: GIP, GLP-1, and glucagon
Complementary Therapies we combine nutritional support with our core services
The peptide does not affect liver metabolism in ways that would interact with alcohol processing
Common side effects (minimal) Most people: No side effects GHK-Cu extremely well-tolerated Natural peptide (found in body) Minimal adverse effects Possible minor effects: Injection site stinging (common, harmless) Minor bruising at injection sites Slight blue tint to injection site (copper, temporary) Mild headache (rare) Managing side effects: Stinging: Inject slowly, warm peptide to room temp Bruising: Rotate sites, proper technique Blue tint: Normal, fades within days Headache: Hydrate well, reduce dose Contraindications and cautions Avoid if: Pregnancy or breastfeeding (no data) Active cancer (theoretical copper concerns) Wilson's disease (copper metabolism disorder) Hemochromatosis (iron overload, copper caution) Use caution with: Copper supplements (avoid taking both) High copper foods (monitor intake) Liver disease (copper metabolism) Generally safe for: All ages (adults) Men and women Long-term use Most health conditions Copper toxicity concerns Is copper in GHK-Cu dangerous
